Supplementary Table S3 from Combination Therapy with Copanlisib and Niraparib in Patients with Recurrent Endometrial and Ovarian Cancer (COPANIRA): Efficacy, Toxicity, and Translational Insights
Year: 2026
Type: supplementary-materials
Abstract: Representativeness of Study Participants
Authors: Allison L. Brodsky, Amma Asare, Bryan Fellman, Kristin Anderson, Jun Yao, Sanghoon Lee, Hai Tran, Xun Xu, Jinsong Liu, Joseph Celestino, Richard A. Hajek, Margaret B. Morgan, Mohammad Mohammad, Pamela Soliman, Aaron Shafer, Anil K. Sood, Diane Bodurka, Nicole D. Fleming, Michaela Onstad Grinsfelder, Ljiljana Milojevic, Amir A. Jazaeri, Gordon B. Mills, Robert L. Coleman, Shannon N. Westin
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7147643364
